Prevalence and determinants of dyslipidemia in Xiangxi minority areas

WANG Haoren; ZHANG Na; TIAN Mengyuan; DING Jian; TAN Hongzhuan

doi:10.16462/j.cnki.zhjbkz.2023.04.010

Volume 27 Issue 4

Apr. 2023

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION > 2023 > 27(4): 431-436

WANG Haoren, ZHANG Na, TIAN Mengyuan, DING Jian, TAN Hongzhuan. Prevalence and determinants of dyslipidemia in Xiangxi minority areas[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2023, 27(4): 431-436. doi: 10.16462/j.cnki.zhjbkz.2023.04.010

Citation:

WANG Haoren, ZHANG Na, TIAN Mengyuan, DING Jian, TAN Hongzhuan. Prevalence and determinants of dyslipidemia in Xiangxi minority areas[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2023, 27(4): 431-436. doi: 10.16462/j.cnki.zhjbkz.2023.04.010

Citation:

PDF( 802 KB)

Prevalence and determinants of dyslipidemia in Xiangxi minority areas

doi: 10.16462/j.cnki.zhjbkz.2023.04.010

1.
Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha 410078, China
2.
Hunan Rehabilitation Hospital, Changsha 410007, China

Funds:

The Science Foundation of Health Commission of Hunan Province in China C2014-17

More Information

Corresponding author: TAN Hongzhuan, E-mail: tanhz99@qq.com
Received Date: 2022-06-24
Rev Recd Date: 2023-09-25

Available Online: 2023-04-28

Publish Date: 2023-04-10

Abstract

Abstract

Objective To understand the prevalence of dyslipidemia and its determinants in Xiangxi minority areas and to provide scientific information for the prevention and control of dyslipidemia. Methods Using the multi-stage random sampling method, 880 residents≥30 yeas old in Xiangxi minority areas were selected for investigation. Meanwhile, the multivariate logistic regression model was used to analyze the possible determinants. Results The prevalence of dyslipidemia was 38.8%, and the prevalence of high total cholesterol, high triglyceride, low high-density lipoprotein cholesterol, and high low-density lipoprotein cholesterol were 7.6%, 18.1%, 23.2%, and 3.9%, respectively. Multivariate logistic regression analysis showed that diabetes mellitus (OR=1.675) and central obesity (OR=2.316) were risk factors for dyslipidemia. While high-intensity physical activity (OR=0.715) and age≥60 years old (OR=0.616) were protective factors for dyslipidemia. Conclusions The prevalence of dyslipidemia is high in Xiangxi minority areas, active and targeted measures should be taken to control dyslipidemia.
- Dyslipidemia,
- Minority,
- Prevalence,
- Determinants

FullText(HTML)

References(21)

References

[1]	中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版)[J]. 中国循环杂志, 2016, 31(10): 937-950. DOI: 10.3969/j.issn.1000-3614.2-16.10.001. Joint Committee on the Revision of Guidelines for the Prevention and Treatment of dyslipidemia in Adults in China. Guidelines for Prevention and treatment of dyslipidemia in adults in China (2016 revised edition)[J]. Chin Circul J, 2016, 31(10): 937-950. DOI: 10.3969/j.issn.1000-3614.2-16.10.001.
[2]	国家卫生计生委疾病预防控制局. 中国居民营养与慢性病状况报告[R]. 人民卫生出版社, 2015. National Health and Family Planning Commission Bureau for Disease Control and Prevention. Report on nutrition and chronic diseases of Chinese residents[R]. People's Medical Publishing House, 2015.
[3]	中国高血压防治指南修订委员会. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1): 24-56. DOI: 10.3969/j.issn.1007-5410.2019.01.002. Writing Group of Chinese Guidelines for the Management of Hypertension. Guidelines for Prevention and treatment of Hypertension in China (revised 2018)[J]. Chin J Cardiovasc Med, 2019, 24(1): 24-56. DOI: 10.3969/j.issn.1007-5410.2019.01.002.
[4]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4): 315-409. DOI: 10.3969/j.issn.1007-5410.2019.01.002. Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)[J]. Chin J Diabetes Mellitus, 2021, 13(4): 315-409. DOI: 10.3969/j.issn.1007-5410.2019.01.002.
[5]	中国肥胖问题工作组数据汇总分析协作组. 我国成人体重指数和腰围对相关疾病危险因素异常的预测价值: 适宜体重指数和腰围切点的研究[J]. 中华流行病学杂志, 2002, 23(1): 5-10. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLX200201002.htm Coorperative Meta-analysis Group of China Obesity Task Force. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population[J]. Chin J Epidemiol, 2002, 23(1): 5-10. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLX200201002.htm
[6]	刘琼. 湖南省2018年成人血脂异常流行特征及其影响因素研究[D]. 衡阳: 南华大学, 2021. Liu Q. Prevalence and Influencing Factors of Dyslipidemia in Adults in Hunan Province, 2018[D]. Hengyang: University of South China, 2021.
[7]	潘敬菊, 何田静, 张岚, 等. 湖北省2013年城乡居民血脂异常患病率及血脂水平和比值分布特征比较[J]. 中国公共卫生, 2017, 33(10): 1439-1444. DOI: 10.11847/zgggws2017-33-10-06. Pan JJ, He TJ, Zhang L, et al. Dyslipidemia prevalence and serum lipid profiles and ratios among urban and rural residents in Hubei province, 2013: a comparison analysis[J]. Chin J Public Health, 2017, 33(10): 1439-1444. DOI: 10.11847/zgggws2017-33-10-06.
[8]	丁贤彬, 许杰, 唐文革, 等. 重庆市35岁及以上居民血脂异常患病率及相关因素分析[J]. 实用预防医学, 2021, 28(4): 412-417. DOI: 10.3969/j.issn.1006-3110.2021.04.002. Ding XB, Xu J, Tang WG, et al. Prevalence rate of dyslipidemia and its related factors among residents aged 35 years and above in Chongqing Municipality[J]. Pract Prev Med, 2021, 28(4): 412-417. DOI: 10.3969/j.issn.1006-3110.2021.04.002.
[9]	孟焕, 邱琳, 飒日娜, 等. 陕西省成人血脂异常流行现状及相关因素研究[J]. 中国慢性病预防与控制, 2021, 29(10): 750-755. DOI: 10.16386/j.cjpccd.issn.1004-6194.2021.10.007. Meng H, Qiu L, Sa RN, et al. Prevalence and related factors of dyslipidemia among adults of Shaanxi Province[J]. Chin J Prev Control Chron Dis, 2021, 29(10): 750-755. DOI: 10.16386/j.cjpccd.issn.1004-6194.2021.10.007.
[10]	赵越, 马爱娟, 方凯, 等. 北京市2014年18~65岁居民血脂异常患病率及其危险因素的相关性研究[J]. 中国临床医生杂志, 2017, 45(11): 25-28. DOI: 10.3969/j.issn.2095-8552.2017.11.009. Zhao Y, Ma AJ, Fang K, et al. Prevalence and risk factors of dyslipidemia among residents aged 18-65 years in Beijing, 2014[J]. Chin J Clinic, 2017, 45(11): 25-28. DOI: 10.3969/j.issn.2095-8552.2017.11.009.
[11]	吴洵, 覃玉, 苏健, 等. 江苏省35~75岁居民血脂异常患病和治疗情况及影响因素分析[J]. 中国慢性病预防与控制, 2020, 28(4): 291-295. DOI: 10.16386/j.cjpccd.issn.1004-6194.2020.04.012. Wu X, Qin Y, Su J, et al. Prevalence, treatment and influencing factors of dyslipidemia in residents aged 35-75 years in Jiangsu province[J]. Chin J Prev Control Chron Dis, 2020, 28(4): 291-295. DOI: 10.16386/j.cjpccd.issn.1004-6194.2020.04.012.
[12]	Tang F, Wang J, Nicholas S, et al. A cohort study on risk factors of high-density lipoprotein cholesterol hypolipidemia among urban Chinese adults[J]. Lipids Health Dis, 2021, 20(1): 20. DOI: 10.1186/s12944-021-01449-1.
[13]	姜博, 马爱娟, 李航, 等. 北京市18-65岁居民高胆固醇血症流行现状与影响因素分析[J]. 中华流行病学杂志, 2017, 38(7): 938-943. DOI: 10.3760/cma.j.issn.0254-6450.2017.07.018. Jiang B, Ma AJ, Li H, et al. Prevalence of hypercholesterolemia and influence factors in residents aged 18-65 years in Beijing[J]. Chin J Epidemiol, 2017, 38(7): 938-943. DOI: 10.3760/cma.j.issn.0254-6450.2017.07.018.
[14]	Trapani L, Pallottini V. Age-Related Hypercholesterolemia and HMG-CoA Reductase Dysregulation: Sex Does Matter (A Gender Perspective)[J]. Curr Gerontol Geriatr Res, 2010: 420139. DOI: 10.1155/2010/420139.
[15]	李亚鹏, 马儒林, 张眉, 等. 2010年新疆维吾尔族、哈萨克族及汉族成年人血脂异常的流行特点[J]. 中华预防医学杂志, 2013, 47(10): 949-953. DOI: 10.3760/cma.j.issn.0253-9642.2013.10.027. Li YP, Ma RL, Zhang M, et al. Epidemic features of dyslipidemia among Uygur, Kazakh, and Han adults in Xinjiang, China in 2010[J]. Chin J Prev Med, 2013, 47(10): 949-953. DOI: 10.3760/cma.j.issn.0253-9642.2013.10.027.
[16]	汪晓洲, 边惠萍, 徐效龙, 等. 青海省藏、汉族居民血脂异常特点分析[J]. 临床荟萃, 2017, 32(5): 413-415. DOI: 10.3969/j.issn.1004-583X.2017.05.009. Wang XZ, Bian HP, Xu XL, et al. Dyslipidemia analysis in Tibetan and Han adult population of Qinghai Province[J]. Clin Focus, 2017, 32(5): 413-415. DOI: 10.3969/j.issn.1004-583X.2017.05.009.
[17]	武恩平, 刘奕廷, 李建彬. 2018年郑州市18岁及以上居民血脂异常流行特征及影响因素分析[J]. 中国慢性病预防与控制, 2019, 27(9): 679-683. DOI: 10.16386/j.cjpccd.issn.1004-6194.2019.09.010. Wu EP, Liu YT, Li JB. Epidemiological characteristics and influencing factors of dyslipidemia among residents aged 18 years and above in Zhengzhou, 2018[J]. Chin J Prev Control Chron Dis, 2019, 27(9): 679-683. DOI: 10.16386/j.cjpccd.issn.1004-6194.2019.09.010.
[18]	刘琼, 金东辉, 刘慧琳, 等. 湖南省2015年成人血脂异常流行水平及影响因素分析[J]. 中国慢性病预防与控制, 2021, 29(4): 278-281. DOI: 10.16386/j.cjpccd.issn.1004-6194.2021.04.009. Liu Q, Jin DH, Liu HL, et al. Prevalence level and influencing factors of dyslipidemia in adult residents of Hunan Province in 2015[J]. Chin J Prev Control Chron Dis, 2021, 29(4): 278-281. DOI: 10.16386/j.cjpccd.issn.1004-6194.2021.04.009.
[19]	贾俊. 南京市建邺区人群血脂异常分布及其相关危险因素分析[D]. 南京: 东南大学, 2018. Jia J. Study on Prevalence and Risk Factors of dyslipidemia among Population in Nanjing Jianye District[D]. Nanjing: Southeast university, 2018.
[20]	胡泊, 刘晓宇, 郭春月, 等. 中年健康人群体力活动与血脂水平关系的横断面研究[J]. 第二军医大学学报, 2016, 37(3): 383-387. DOI: 10.16781/j.0258-879x.2016.03.0383. Hu B, Liu XY, Guo CY, et al. Relationship between physical activity and lipid profile in healthy middle-aged Chinese population: a cross-sectional study[J]. Acad J Second Military Med Univ, 2016, 37(3): 383-387. DOI: 10.16781/j.0258-879x.2016.03.0383.
[21]	Leon AS, Sanchez OA. Response of blood lipids to exercise training alone or combined with dietary intervention[J]. Med Sci Sports Exerc, 2001, 33(6 Suppl): S502-S515, S528-S529. DOI: 10.1097/00005768-200106001-00021.